1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NEOD001 demonstrates organ biomarker responses in patients with light chain amyloidosis and persistent organ dysfunction independently of previous hematologic response
    Meeting Abstract

    Liedtke, M.; Comenzo, R. L.; Landau, H.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schönland, S. O.; Walling, J.; Kinney, G. G.; Koller, M.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Bosutinib (BOS) vs imatinib (IM) for newly diagnosed chronic myeloid leukemia (CML): Initial results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Le Coutre, P.; Jentsch-Ullrich, K.; Waller, C.; Wolf, D.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Literature review of TPOR agonists for CIT
    Meeting Abstract

    Soff, G. A.; Ray-Coquard, I.; Marfil-Rivera, L. J.; Fryzek, J.; Mullins, M.; Bylsma, L. C.; Park, J. K.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer
    Meeting Abstract

    Wainberg, Z. A.; Jalal, S.; Muro, K.; Yoon, H. H.; Garrido, M.; Golan, T.; Doi, T.; Catenacci, D. V.; Geva, R.; Ku, G.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase 2a study of a novel stapled peptide ALRN-6924 disrupting MDMX- and MDM2-mediated inhibition of wild-type TP53 in patients with peripheral t-cell lymphoma
    Meeting Abstract

    Payton, M.; Pinchasik, D.; Mehta, A.; Goel, S.; Zain, J. M.; Sokol, L.; Jacobsen, E.; Patel, M. R.; Horwitz, S. M.; Meric-Bernstam, F.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase III randomized, double-blind, controlled studies of the PI3K inhibitor copanlisib in combination with rituximab or rituximab-based chemotherapy in subjects with relapsed indolent B-cell non-Hodgkin's lymphoma (iNHL): CHRONOS-3 and CHRONOS-4
    Meeting Abstract

    Gerecitano, J.; Zheng, H.; Mongay Soler, L.; Ito, R.; Reis, D.; Lu, C.; Shen, J.; Childs, B. H.; Zinzani, P. L.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Pharmacodynamic and pharmacokinetic evaluation of SY-1425 (tamibarotene) in biomarker-selected acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients
    Meeting Abstract

    Bixby, D.; Vigil, C. E.; Jurcic, J.; Cook, R.; Sekeres, M. A.; Rizzieri, D.; Cortes, J.; Redner, R.; Steensma, D.; Roboz, G.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Chemotherapy-induced thrombocytopenia (CIT) in metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Cetin, K.; Toler, A.; Eisen, M.; Soff, G. A.
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab treatment in chemotherapy-naïve patients with distant metastatic Merkel cell carcinoma (mMCC)
    Meeting Abstract

    D'Angelo, S. P.; Russell, J.; Hassel, J.; Lebbé, C.; Chmielowski, B.; Rabinowits, G.; Terheyden, P.; Brownell, I.; Zwiener, I.; Bajars, M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Diagnosis of extrapulmonary legionellosis in allogeneic hematopoietic cell transplant recipients by direct 16S ribosomal ribonucleic acid sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Journal Article

    Franco-Garcia, A.; Varughese, T. A.; Lee, Y. J.; Papanicolaou, G.; Rosenblum, M. K.; Hollmann, T. J.; Koehne, G.; Boulad, F.; Babady, N. E.; Tang, Y. W.; more...
    Open Forum Infectious Diseases (2017)

    Fulltext@MSK | Save